Madan L. Arora, MD, discusses the evolution of treatment in follicular lymphoma.
Madan L. Arora, MD, clinical associate professor, medicine, Michigan State University, College of Human Medicine, discusses the evolution of treatment in follicular lymphoma.
Significant progress has been made in the treatment landscape for patients with follicular lymphoma, with the addition of several new agents, Arora says. This multitude of available options has improved the overall survival of patients, Arora adds.
Patients are now able to receive a fixed duration of therapy that has led to prolonged survival for a majority of patients while maintaining a reasonable quality of life, Arora concludes.